Jonathan Anderman serves as the General Counsel and Corporate Secretary at COMPASS THERAPEUTICS, a biopharmaceutical company focused on developing innovative therapies for cancer treatment. In his role, Anderman is responsible for overseeing all legal matters, ensuring compliance with regulatory requirements, and providing strategic guidance to the executive team. His expertise in corporate governance and intellectual property law has been instrumental in navigating the complex landscape of the biopharmaceutical industry. Prior to joining COMPASS THERAPEUTICS, Anderman held several key positions in the legal field, amassing a wealth of experience that he brings to his current role. He previously served as a partner at a prestigious law firm, where he specialized in life sciences and technology transactions. During his tenure, he successfully negotiated numerous high-stakes deals and advised clients on a wide range of legal issues, from mergers and acquisitions to patent litigation. Anderman's ability to provide comprehensive legal support while fostering strong client relationships has earned him a reputation as a trusted advisor in the industry. Anderman's achievements extend beyond his professional accomplishments. He is an active member of several industry associations and has been recognized for his contributions to the field of biopharmaceutical law. His thought leadership and dedication to advancing the industry have made him a sought-after speaker at conferences and seminars. At COMPASS THERAPEUTICS, Anderman plays a crucial role in shaping the company's strategic direction, ensuring that legal considerations are seamlessly integrated into the company's growth and development plans. His commitment to excellence and his passion for improving patient outcomes through innovative therapies make him an invaluable asset to the COMPASS THERAPEUTICS team.